Dose Density FU 75 and FU 90 as Adjuvant Therapy for Early Breast Cancer
NCT00286819
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
the FEC75 and 95 regimen
Sponsor
Central European Cooperative Oncology Group